Latest Technology Platforms News

Metallium Limited has raised A$75 million in a strategic capital round led by U.S. institutional investors, accelerating its commercial operations in Texas and setting the stage for a NASDAQ listing later this year.

Noxopharm has successfully completed the final multiple-dose cohort of its HERACLES trial for SOF-SKN™, reporting no significant safety concerns and paving the way for Phase II-enabling studies.

Atomo Diagnostics has locked in exclusive global rights to a novel liver function test that rapidly detects liver injury, expanding its footprint in point-of-care diagnostics. The test, delivered on Atomo’s Pascal platform, targets drug-induced liver injury and chronic liver conditions with significant commercial potential.

Alcidion Group has been named preferred supplier for a major UK hospital's Electronic Patient Record system, driving a 40% jump in contracted revenue and a robust cash position in Q2 FY26.

Argent BioPharma has signed a binding agreement to acquire AusCann’s 48% stake in CannPal, enhancing its clinical and intellectual property assets for CannEpil®. The deal includes an option for the Neuvis® drug-delivery platform and aligns with Argent’s U.S. dual-listing ambitions.

Electro Optic Systems (EOS) has acquired European defence tech firm MARSS, integrating advanced AI-enabled command and control systems to create a comprehensive counter-drone solution. This strategic move positions EOS as a prime contractor for larger defence programs and expands its global footprint.

Eden Innovations has secured a $2.2 million strategic investment to fully repay its remaining iBorrow debt, eliminating costly interest payments and strengthening its balance sheet ahead of anticipated revenue growth.

Metallium’s US subsidiary has locked in a binding multi-year supply agreement with Glencore for electronic scrap, underpinning the commercial scale-up of its innovative Flash Joule Heating technology in Texas.

Temas Resources has fortified its position in the critical minerals sector through key strategic moves including joining Québec’s CSM Scientific Network, engaging market-making services, and commissioning independent equity research.

EPX Limited has successfully completed a $2.14 million private placement to institutional investors, positioning itself to acquire Wattwatchers Pty Limited and invest in new technology initiatives. An upcoming Share Purchase Plan will offer existing shareholders further participation opportunities.

nib holdings limited signals higher-than-expected non-recurring expenses in the first half of 2026, impacting statutory profit but leaving underlying performance steady.

EPX Limited has secured Wattwatchers Pty Limited through a Deed of Company Arrangement, backed by a $2.14 million placement and a Share Purchase Plan to raise additional funds. This strategic move enhances EPX’s energy monitoring capabilities and recurring revenue streams.